Global Wound Care Biologics Market to Reach $5 Billion by 2030

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

 | Source: ReportLinker ReportLinker

New York, May 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Wound Care Biologics Industry" - https://www.reportlinker.com/p06033318/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Wound Care Biologics Market to Reach $5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Wound Care Biologics estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$5 Billion by 2030, growing at aCAGR of 14.1% over the period 2022-2030. Biologic Skin Substitutes, one of the segments analyzed in the report, is projected to record 14.8% CAGR and reach US$3.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Topical Agents segment is readjusted to a revised 12.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $473.1 Million, While China is Forecast to Grow at 20.4% CAGR

The Wound Care Biologics market in the U.S. is estimated at US$473.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 20.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 12.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Select Competitors (Total 42 Featured)
- Acell
- Anika Therapeutics
- Integra Lifesciences
- Kerecis
- Marine Polymer Technologies
- Mimedx Group
- Mölnlycke Health Care AB (Investor AB)
- Organogenesis
- Osiris Therapeutics
- Smith & Nephew


Read the full report: https://www.reportlinker.com/p06033318/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Wound Care Biologics - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Wound
Care Biologics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Wound Care Biologics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Wound Care Biologics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Biologic Skin Substitutes by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Biologic Skin Substitutes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for Biologic Skin
Substitutes by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Topical Agents by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Topical Agents by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 9: World 16-Year Perspective for Topical Agents by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Ulcers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Ulcers by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 12: World 16-Year Perspective for Ulcers by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Surgical & Traumatic Wounds by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Surgical & Traumatic Wounds
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 15: World 16-Year Perspective for Surgical & Traumatic
Wounds by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 16: World Recent Past, Current & Future Analysis for
Burns by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 17: World Historic Review for Burns by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 18: World 16-Year Perspective for Burns by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 21: World 16-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for ASCs
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 23: World Historic Review for ASCs by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 24: World 16-Year Perspective for ASCs by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for Burn
Centers & Wound Clinics by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2022 through 2030 and % CAGR

Table 26: World Historic Review for Burn Centers & Wound
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 27: World 16-Year Perspective for Burn Centers & Wound
Clinics by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 28: World Wound Care Biologics Market Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
Wound Care Biologics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 29: USA Recent Past, Current & Future Analysis for Wound
Care Biologics by Product - Biologic Skin Substitutes and
Topical Agents - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 30: USA Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 31: USA 16-Year Perspective for Wound Care Biologics by
Product - Percentage Breakdown of Value Sales for Biologic Skin
Substitutes and Topical Agents for the Years 2014, 2023 & 2030

Table 32: USA Recent Past, Current & Future Analysis for Wound
Care Biologics by Wound Type - Ulcers, Surgical & Traumatic
Wounds and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 33: USA Historic Review for Wound Care Biologics by Wound
Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 34: USA 16-Year Perspective for Wound Care Biologics by
Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2014, 2023 &
2030

Table 35: USA Recent Past, Current & Future Analysis for Wound
Care Biologics by End-Use - Hospitals, ASCs and Burn Centers &
Wound Clinics - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 36: USA Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 37: USA 16-Year Perspective for Wound Care Biologics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2014, 2023 &
2030

CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Wound Care Biologics by Product - Biologic Skin Substitutes and
Topical Agents - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 39: Canada Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 40: Canada 16-Year Perspective for Wound Care Biologics
by Product - Percentage Breakdown of Value Sales for Biologic
Skin Substitutes and Topical Agents for the Years 2014, 2023 &
2030

Table 41: Canada Recent Past, Current & Future Analysis for
Wound Care Biologics by Wound Type - Ulcers, Surgical &
Traumatic Wounds and Burns - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 42: Canada Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 43: Canada 16-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2014, 2023 &
2030

Table 44: Canada Recent Past, Current & Future Analysis for
Wound Care Biologics by End-Use - Hospitals, ASCs and Burn
Centers & Wound Clinics - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 45: Canada Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 46: Canada 16-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2014, 2023 &
2030

JAPAN
Wound Care Biologics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Wound Care Biologics by Product - Biologic Skin Substitutes and
Topical Agents - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 48: Japan Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 49: Japan 16-Year Perspective for Wound Care Biologics by
Product - Percentage Breakdown of Value Sales for Biologic Skin
Substitutes and Topical Agents for the Years 2014, 2023 & 2030

Table 50: Japan Recent Past, Current & Future Analysis for
Wound Care Biologics by Wound Type - Ulcers, Surgical &
Traumatic Wounds and Burns - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 51: Japan Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 52: Japan 16-Year Perspective for Wound Care Biologics by
Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2014, 2023 &
2030

Table 53: Japan Recent Past, Current & Future Analysis for
Wound Care Biologics by End-Use - Hospitals, ASCs and Burn
Centers & Wound Clinics - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 54: Japan Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 55: Japan 16-Year Perspective for Wound Care Biologics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2014, 2023 &
2030

CHINA
Wound Care Biologics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 56: China Recent Past, Current & Future Analysis for
Wound Care Biologics by Product - Biologic Skin Substitutes and
Topical Agents - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 57: China Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 58: China 16-Year Perspective for Wound Care Biologics by
Product - Percentage Breakdown of Value Sales for Biologic Skin
Substitutes and Topical Agents for the Years 2014, 2023 & 2030

Table 59: China Recent Past, Current & Future Analysis for
Wound Care Biologics by Wound Type - Ulcers, Surgical &
Traumatic Wounds and Burns - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 60: China Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 61: China 16-Year Perspective for Wound Care Biologics by
Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2014, 2023 &
2030

Table 62: China Recent Past, Current & Future Analysis for
Wound Care Biologics by End-Use - Hospitals, ASCs and Burn
Centers & Wound Clinics - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 63: China Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 64: China 16-Year Perspective for Wound Care Biologics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2014, 2023 &
2030

EUROPE
Wound Care Biologics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 65: Europe Recent Past, Current & Future Analysis for
Wound Care Biologics by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 66: Europe Historic Review for Wound Care Biologics by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 67: Europe 16-Year Perspective for Wound Care Biologics
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2014, 2023 & 2030

Table 68: Europe Recent Past, Current & Future Analysis for
Wound Care Biologics by Product - Biologic Skin Substitutes and
Topical Agents - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 69: Europe Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 70: Europe 16-Year Perspective for Wound Care Biologics
by Product - Percentage Breakdown of Value Sales for Biologic
Skin Substitutes and Topical Agents for the Years 2014, 2023 &
2030

Table 71: Europe Recent Past, Current & Future Analysis for
Wound Care Biologics by Wound Type - Ulcers, Surgical &
Traumatic Wounds and Burns - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 72: Europe Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 73: Europe 16-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2014, 2023 &
2030

Table 74: Europe Recent Past, Current & Future Analysis for
Wound Care Biologics by End-Use - Hospitals, ASCs and Burn
Centers & Wound Clinics - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 75: Europe Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 76: Europe 16-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2014, 2023 &
2030

FRANCE
Wound Care Biologics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 77: France Recent Past, Current & Future Analysis for
Wound Care Biologics by Product - Biologic Skin Substitutes and
Topical Agents - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 78: France Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 79: France 16-Year Perspective for Wound Care Biologics
by Product - Percentage Breakdown of Value Sales for Biologic
Skin Substitutes and Topical Agents for the Years 2014, 2023 &
2030

Table 80: France Recent Past, Current & Future Analysis for
Wound Care Biologics by Wound Type - Ulcers, Surgical &
Traumatic Wounds and Burns - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 81: France Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 82: France 16-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2014, 2023 &
2030

Table 83: France Recent Past, Current & Future Analysis for
Wound Care Biologics by End-Use - Hospitals, ASCs and Burn
Centers & Wound Clinics - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 84: France Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 85: France 16-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2014, 2023 &
2030

GERMANY
Wound Care Biologics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 86: Germany Recent Past, Current & Future Analysis for
Wound Care Biologics by Product - Biologic Skin Substitutes and
Topical Agents - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 87: Germany Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 88: Germany 16-Year Perspective for Wound Care Biologics
by Product - Percentage Breakdown of Value Sales for Biologic
Skin Substitutes and Topical Agents for the Years 2014, 2023 &
2030

Table 89: Germany Recent Past, Current & Future Analysis for
Wound Care Biologics by Wound Type - Ulcers, Surgical &
Traumatic Wounds and Burns - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 90: Germany Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 91: Germany 16-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2014, 2023 &
2030

Table 92: Germany Recent Past, Current & Future Analysis for
Wound Care Biologics by End-Use - Hospitals, ASCs and Burn
Centers & Wound Clinics - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 93: Germany Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 94: Germany 16-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2014, 2023 &
2030

ITALY
Table 95: Italy Recent Past, Current & Future Analysis for
Wound Care Biologics by Product - Biologic Skin Substitutes and
Topical Agents - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 96: Italy Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 97: Italy 16-Year Perspective for Wound Care Biologics by
Product - Percentage Breakdown of Value Sales for Biologic Skin
Substitutes and Topical Agents for the Years 2014, 2023 & 2030

Table 98: Italy Recent Past, Current & Future Analysis for
Wound Care Biologics by Wound Type - Ulcers, Surgical &
Traumatic Wounds and Burns - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 99: Italy Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 100: Italy 16-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2014, 2023 &
2030

Table 101: Italy Recent Past, Current & Future Analysis for
Wound Care Biologics by End-Use - Hospitals, ASCs and Burn
Centers & Wound Clinics - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 102: Italy Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 103: Italy 16-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2014, 2023 &
2030

UNITED KINGDOM
Wound Care Biologics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 104: UK Recent Past, Current & Future Analysis for Wound
Care Biologics by Product - Biologic Skin Substitutes and
Topical Agents - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 105: UK Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 106: UK 16-Year Perspective for Wound Care Biologics by
Product - Percentage Breakdown of Value Sales for Biologic Skin
Substitutes and Topical Agents for the Years 2014, 2023 & 2030

Table 107: UK Recent Past, Current & Future Analysis for Wound
Care Biologics by Wound Type - Ulcers, Surgical & Traumatic
Wounds and Burns - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 108: UK Historic Review for Wound Care Biologics by Wound
Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 109: UK 16-Year Perspective for Wound Care Biologics by
Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2014, 2023 &
2030

Table 110: UK Recent Past, Current & Future Analysis for Wound
Care Biologics by End-Use - Hospitals, ASCs and Burn Centers &
Wound Clinics - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 111: UK Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 112: UK 16-Year Perspective for Wound Care Biologics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2014, 2023 &
2030

SPAIN
Table 113: Spain Recent Past, Current & Future Analysis for
Wound Care Biologics by Product - Biologic Skin Substitutes and
Topical Agents - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 114: Spain Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 115: Spain 16-Year Perspective for Wound Care Biologics
by Product - Percentage Breakdown of Value Sales for Biologic
Skin Substitutes and Topical Agents for the Years 2014, 2023 &
2030

Table 116: Spain Recent Past, Current & Future Analysis for
Wound Care Biologics by Wound Type - Ulcers, Surgical &
Traumatic Wounds and Burns - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 117: Spain Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 118: Spain 16-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2014, 2023 &
2030

Table 119: Spain Recent Past, Current & Future Analysis for
Wound Care Biologics by End-Use - Hospitals, ASCs and Burn
Centers & Wound Clinics - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 120: Spain Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 121: Spain 16-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2014, 2023 &
2030

RUSSIA
Table 122: Russia Recent Past, Current & Future Analysis for
Wound Care Biologics by Product - Biologic Skin Substitutes and
Topical Agents - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 123: Russia Historic Review for Wound Care Biologics by
Product - Biologic Skin Substitutes and Topical Agents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 124: Russia 16-Year Perspective for Wound Care Biologics
by Product - Percentage Breakdown of Value Sales for Biologic
Skin Substitutes and Topical Agents for the Years 2014, 2023 &
2030

Table 125: Russia Recent Past, Current & Future Analysis for
Wound Care Biologics by Wound Type - Ulcers, Surgical &
Traumatic Wounds and Burns - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 126: Russia Historic Review for Wound Care Biologics by
Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 127: Russia 16-Year Perspective for Wound Care Biologics
by Wound Type - Percentage Breakdown of Value Sales for Ulcers,
Surgical & Traumatic Wounds and Burns for the Years 2014, 2023 &
2030

Table 128: Russia Recent Past, Current & Future Analysis for
Wound Care Biologics by End-Use - Hospitals, ASCs and Burn
Centers & Wound Clinics - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 129: Russia Historic Review for Wound Care Biologics by
End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 130: Russia 16-Year Perspective for Wound Care Biologics
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
ASCs and Burn Centers & Wound Clinics for the Years 2014, 2023 &
2030

REST OF EUROPE
Table 131: Rest of Europe Recent Past, Current & Future
Analysis for Wound Care Biologics by Product - Biologic Skin
Substitutes and Topical Agents - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 132: Rest of Europe Historic Review for Wound Care
Biologics by Product - Biologic Skin Substitutes and Topical
Agents Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 133: Rest of Europe 16-Year Perspective for Wound Care
Biologics by Product - Percentage Breakdown of Value Sales for

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033318/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

 

            











    

        

        
Contact Data

        


    
    

 
    



        

        
            GlobeNewswire